Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients

doi:10.5306/wjco.v9.i7.140

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6573)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

449

WORD

300

HTML

3237

Figures (1-3)

226

Tables (1-4)

240

Sum=4452

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

872

Download

1249

Sum=2121

Nov 10, 2018 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Nov 10, 2018; 9(7): 140-147
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.140

Table 3 Correlation between Karnofsky performance status and Eastern Cooperative Oncology Group performance status

Visit number	Number of assessments	Spearman’s correlation coefficient¹
1	1426	-0.727
2	1099	-0.890
3	957	-0.876
4	823	-0.863
5	602	-0.858
6	464	-0.867
7	270	-0.901
8	129	-0.854
9	54	-0.773
10	20	-0.972
Overall	5844	-0.840

¹P < 0.0001 for all individual visits and overall.

Citation: Prasad KT, Kaur H, Muthu V, Aggarwal AN, Behera D, Singh N. Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients. World J Clin Oncol 2018; 9(7): 140-147
URL: https://www.wjgnet.com/2218-4333/full/v9/i7/140.htm
DOI: https://dx.doi.org/10.5306/wjco.v9.i7.140